Cargando…

A Review of the Hereditary Component of Triple Negative Breast Cancer: High- and Moderate-Penetrance Breast Cancer Genes, Low-Penetrance Loci, and the Role of Nontraditional Genetic Elements

Triple negative breast cancer (TNBC), representing 10-15% of breast tumors diagnosed each year, is a clinically defined subtype of breast cancer associated with poor prognosis. The higher incidence of TNBC in certain populations such as young women and/or women of African ancestry and a unique patho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ellsworth, Darrell L., Turner, Clesson E., Ellsworth, Rachel E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6652078/ https://www.ncbi.nlm.nih.gov/pubmed/31379942 http://dx.doi.org/10.1155/2019/4382606

Ejemplares similares

Should Genetic Testing for Cancer Predisposition Be Standard-of-Care for Women with Invasive Breast Cancer? The Murtha Cancer Center Experience
por: Rummel, Seth K., et al.
Publicado: (2020)

Breast Cancer in the Personal Genomics Era
por: Ellsworth, Rachel E., et al.
Publicado: (2010)

Management of Incidental Findings in the Era of Next-generation Sequencing
por: Blackburn, Heather L., et al.
Publicado: (2015)

Heritability of Low ER Staining/HER2-Breast Tumors: Are We Missing an Opportunity for Germline Testing?
por: Lovejoy, Leann A., et al.
Publicado: (2020)

Cancer Previvors in an Active Duty Service Women Population: An Opportunity for Prevention and Increased Force Readiness
por: Lovejoy, Leann A, et al.
Publicado: (2021)

Genomic Heterogeneity of Breast Tumor Pathogenesis
por: Ellsworth, Rachel E., et al.
Publicado: (2009)

Outcome disparities in African American women with triple negative breast cancer: a comparison of epidemiological and molecular factors between African American and Caucasian women with triple negative breast cancer
por: Sturtz, Lori A, et al.
Publicado: (2014)

Impact of High-to-Moderate Penetrance Genes on Genetic Testing: Looking over Breast Cancer
por: Turchiano, Antonella, et al.
Publicado: (2023)

The search for low-penetrance breast cancer genes
por: Ponder, BAJ, et al.
Publicado: (2005)

Identification of highly penetrant Rb-related synthetic lethal interactions in triple negative breast cancer
por: Brough, Rachel, et al.
Publicado: (2018)

Combined effect of low-penetrant SNPs on breast cancer risk
por: Harlid, S, et al.
Publicado: (2012)

Heterogeneous drug penetrance of veliparib and carboplatin measured in triple negative breast tumors
por: Bartelink, Imke H., et al.
Publicado: (2017)

Tumor penetrating peptides inhibiting MYC as a potent targeted therapeutic strategy for triple-negative breast cancers
por: Wang, Edina, et al.
Publicado: (2018)

Effect of obesity on molecular characteristics of invasive breast tumors: gene expression analysis in a large cohort of female patients
por: Toro, Allyson L., et al.
Publicado: (2016)

Influence of family history on penetrance of hereditary cancers in a population setting
por: Jackson, Leigh, et al.
Publicado: (2023)

Risk‐reducing mastectomy decisions among women with mutations in high‐ and moderate‐ penetrance breast cancer susceptibility genes
por: Comeaux, Jacob G., et al.
Publicado: (2022)

Systematic search for enhancer elements and somatic allelic imbalance at seven low-penetrance colorectal cancer predisposition loci
por: Niittymäki, Iina, et al.
Publicado: (2011)

Eligibility, uptake and response to germline genetic testing in women with DCIS
por: Turza, Lauren, et al.
Publicado: (2022)

Common low-penetrance risk variants associated with breast cancer in Polish women
por: Ledwoń, Joanna K, et al.
Publicado: (2013)

Targeting the EGFR/PCNA Signaling Suppresses Tumor Growth of Triple-Negative Breast Cancer Cells with Cell-Penetrating PCNA Peptides
por: Yu, Yung-Luen, et al.
Publicado: (2013)

Cell-Penetrating Peptide-Modified Graphene Oxide Nanoparticles Loaded with Rictor siRNA for the Treatment of Triple-Negative Breast Cancer
por: Yang, Yun-Yun, et al.
Publicado: (2021)

Candidate Modifier Genes for the Penetrance of Leber’s Hereditary Optic Neuropathy
por: Cheng, Hui-Chen, et al.
Publicado: (2022)

Low disease risk and penetrance in Leber hereditary optic neuropathy
por: Watson, Eloise C., et al.
Publicado: (2023)

Is the disease risk and penetrance in Leber hereditary optic neuropathy actually low?
por: Mackey, David A., et al.
Publicado: (2023)

Penetrance of Breast Cancer Susceptibility Genes From the eMERGE III Network
por: Fan, Xiao, et al.
Publicado: (2021)

Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer
por: Gaudet, Mia M., et al.
Publicado: (2010)

Moderate penetrance genes complicate genetic testing for breast cancer diagnosis: ATM, CHEK2, BARD1 and RAD51D
por: Graffeo, R., et al.
Publicado: (2022)

Health influenced by genetics: A first comprehensive analysis of breast cancer high and moderate penetrance susceptibility genes in the Tunisian population
por: Boujemaa, Maroua, et al.
Publicado: (2022)

Pilot Study on Low Penetrance Breast and Colorectal Cancer Predisposition Markers in Latvia
por: Irmejs, Arvids, et al.
Publicado: (2006)

Quantifying the cumulative effect of low-penetrance genetic variants on breast cancer risk
por: Smyth, Conor, et al.
Publicado: (2015)

Recent applications of cell-penetrating peptide guidance of nanosystems in breast and prostate cancer
por: Longoria-García, Samuel, et al.
Publicado: (2022)

Molecular Alterations Associated with Breast Cancer Mortality
por: Voeghtly, Laura M., et al.
Publicado: (2012)

PSPHL and breast cancer in African American women: causative gene or population stratification?
por: Rummel, Seth, et al.
Publicado: (2014)

Evaluating the breast cancer predisposition role of rare variants in genes associated with low-penetrance breast cancer risk SNPs
por: Li, Na, et al.
Publicado: (2018)

A Female Patient with Down Syndrome and Low-Penetrance Leber's Hereditary Optic Neuropathy
por: Frousiakis, Starleen E., et al.
Publicado: (2014)

Correction: Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer
por: Gaudet, Mia M., et al.
Publicado: (2010)

Correction: Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer
por: Gaudet, Mia M., et al.
Publicado: (2010)

THE KINETICS OF PENETRATION : VI. SOME FACTORS AFFECTING PENETRATION
por: Osterhout, W. J. V., et al.
Publicado: (1934)

Prevalence and Clinicopathological Characteristics of Moderate and High-Penetrance Genes in Non-BRCA1/2 Breast Cancer High-Risk Spanish Families
por: Fonfria, Maria, et al.
Publicado: (2021)

Penetration of capecitabine and its metabolites into malignant and healthy tissues of patients with advanced breast cancer
por: Mader, R M, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_o8jm92tvr6ru2drbqd28oat7q9